戻る Agenda
Session 2: Good Regulatory Practices in the North Africa Region and Beyond
Session Chair(s)
![Smail Nahmed](/_Images/member/Generic_Image_Missing-Profile.jpg)
Smail Nahmed
Regulatory Affairs Manager North and West Africa
Merck, Morocco
Myriam Sedrati
Regulatory Affairs Director North and West Africa
Merck Sharp & Dohme, Morocco
Session 2: Good Regulatory Practices in the North Africa Region and Beyond
Speaker(s)
Good Regulatory Practices Guidelines: Current Status
Samvel Azatyan, MD, PhD
World Health Organization (WHO), Switzerland
Team Lead, Regulatory Convergence and Networks (RCN/REG)
Updates on the processes on the implementation of Good Regulatory Practices from: Morocco
Imane Haouach
Direction du Médicament et de la Pharmacie (DMP), Morocco
Head of Evaluation Services, National Laboratory for Medicines Control
![Wassila Ouerghi](/_Images/member/Generic_Image_Missing-Profile.jpg)
Updates on the processes on the implementation of Good Regulatory Practices from: Tunisia
Wassila Ouerghi
Ministry of Health, Tunisia
Head of Legal Affairs at the Legal Department
Feedback on fast-tracking (EMA, FDA, SFDA, Jordan, Egypt)
Heba Nabil
Pfizer, Egypt
Regulatory Affairs Senior Manager